Eagle Rock Investment Company’s Thermo Fisher Scientific TMO Stock Holding History

Eagle Rock Investment Company’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.4M	Buy	28,655 +4,981	+21%	+$2.39M	1.78%	17
2026 Q1	$11.6M	Buy	23,674 +1,705	+8%	+$925K	1.69%	17
2025 Q4	$12.7M	Buy	21,969 +3,012	+16%	+$1.7M	1.8%	16
2025 Q3	$9.19M	Buy	18,957 +8,246	+77%	+$3.84M	1.35%	21
2025 Q2	$4.34M	Buy	10,711 +3,222	+43%	+$1.35M	0.69%	41
2025 Q1	$3.73M	Buy	7,489 +26	+0.3%	+$14.1K	0.64%	44
2024 Q4	$3.88M	Buy	7,463 +19	+0.3%	+$10.4K	0.65%	43
2024 Q3	$4.6M	Hold	7,444	–	–	0.77%	39
2024 Q2	$4.12M	Buy	7,444 +1,990	+36%	+$1.14M	0.74%	41
2024 Q1	$3.17M	Buy	5,454 +500	+10%	+$281K	0.59%	51
2023 Q4	$2.63M	Hold	4,954	–	–	0.54%	52
2023 Q3	$2.51M	Hold	4,954	–	–	0.57%	50
2023 Q2	$2.6M	Sell	4,954 -38	-0.8%	-$20.5K	0.56%	49
2023 Q1	$2.88M	Buy	4,992 +54	+1%	+$30.4K	0.66%	45
2022 Q4	$2.88M	Buy	4,938 +513	+12%	+$272K	0.66%	44
2022 Q3	$2.24M	Hold	4,425	–	–	0.59%	51
2022 Q2	$2.4M	Buy	4,425 +15	+0.3%	+$8.26K	0.59%	47
2022 Q1	$2.6M	Hold	4,410	–	–	0.55%	47
2021 Q4	$2.94M	Buy	+4,410	New	+$2.75M	0.56%	50

Other funds holding TMO

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Eagle Rock Investment Company's TMO Position: Q2 2026 in Review

Eagle Rock Investment Company increased its Thermo Fisher Scientific (TMO) stake by 21% in Q2 2026, buying an estimated $2.39M and bringing the position to 28,655 shares worth $14.4M. The position accounts for 1.78% of the portfolio, ranked #17.

Eagle Rock Investment Company first reported a position in TMO in Q4 2021 and has held it in 19 quarters since. 1,060 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Eagle Rock Investment Company held 28,655 shares of Thermo Fisher Scientific worth $14.4M as of Q2 2026.
Eagle Rock Investment Company bought 4,981 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.39M.
Thermo Fisher Scientific made up 1.78% of Eagle Rock Investment Company's portfolio in Q2 2026, its #17 holding.
Eagle Rock Investment Company first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 19 quarters since.
1,060 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Eagle Rock Investment Company's 13F filing for Q2 2026, filed 9 Jul 2026.